Study summary · research use only
Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This narrative review discusses oxytocin and oxytocin-like agonists and antagonists acting via the oxytocin receptor in the male reproductive tract, revisiting research dating back over 60 years and connecting it to more recently described roles for oxytocin in male reproductive health. The authors describe local expression of oxytocin and its receptor across different species in the male reproductive tract, colocalization and possible crosstalk with other agents and receptors, and newly reported oxytocin signaling pathways beyond contractility. The abstract reviews the structure and effects of oxytocin-agonists and -antagonists considered for male disorders originating in the reproductive tract, such as prostate diseases and ejaculatory disorders.
Abstract
In this review, the role of oxytocin and oxytocin-like agents (acting via the oxytocin receptor and belonging to the oxytocin-family) in the male reproductive tract is considered. Previous research (dating back over 60 years) is revised and connected with recently found aspects of the role oxytocin plays in male reproductive health. The local expression of oxytocin and its receptor in the male reproductive tract of different species is summarized. Colocalization and possible crosstalk to other agents and receptors and their resulting effects are discussed. The role of the newly reported oxytocin focused signaling pathways in the male reproductive tract, other than mediating contractility, is critically examined. The structure and effect of the most promising oxytocin-agonists and -antagonists are reviewed for their potential in treating male disorders with origins in the male reproductive tract such as prostate diseases and ejaculatory disorders.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.